Schedule 13G ownership disclosure

IMMUNOCORE HOLDINGS PLC

ADR · CUSIP: 45258D105

Event date: 2025-03-31

Filing-level shares
7,051,818
Percent of class
14.1%
  • T. Rowe Price Investment Management, Inc.

    Shares: 7,051,818 · Class: 14.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001897612-25-000217
Form type
SCHEDULE 13G/A
Filer
Immunocore Holdings plc
CIK
CIK 1671927
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub